Literature DB >> 32015995

Is there a role for immunotherapy in ovarian cancer?

Gaia Giannone1,2, Giorgio Valabrega1,2.   

Abstract

Entities:  

Year:  2019        PMID： 32015995      PMCID： PMC6976429          DOI： 10.21037/atm.2019.12.13

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  23 in total

1.  Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Authors:  Corey J Langer; Shirish M Gadgeel; Hossein Borghaei; Vassiliki A Papadimitrakopoulou; Amita Patnaik; Steven F Powell; Ryan D Gentzler; Renato G Martins; James P Stevenson; Shadia I Jalal; Amit Panwalkar; James Chih-Hsin Yang; Matthew Gubens; Lecia V Sequist; Mark M Awad; Joseph Fiore; Yang Ge; Harry Raftopoulos; Leena Gandhi
Journal:  Lancet Oncol       Date:  2016-10-10       Impact factor: 41.316

2.  ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.

Authors:  N Colombo; C Sessa; A du Bois; J Ledermann; W G McCluggage; I McNeish; P Morice; S Pignata; I Ray-Coquard; I Vergote; T Baert; I Belaroussi; A Dashora; S Olbrecht; F Planchamp; D Querleu
Journal:  Ann Oncol       Date:  2019-05-01       Impact factor: 32.976

3.  Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

Authors:  Wei-Ting Hwang; Sarah F Adams; Emin Tahirovic; Ian S Hagemann; George Coukos
Journal:  Gynecol Oncol       Date:  2011-10-29       Impact factor: 5.482

4.  PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

Authors:  Wendy A Cooper; Thang Tran; Ricardo E Vilain; Jason Madore; Christina I Selinger; Maija Kohonen-Corish; PoYee Yip; Bing Yu; Sandra A O'Toole; Brian C McCaughan; Jennifer H Yearley; Lisa G Horvath; Steven Kao; Michael Boyer; Richard A Scolyer
Journal:  Lung Cancer       Date:  2015-05-18       Impact factor: 5.705

5.  PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.

Authors:  John R Webb; Katy Milne; David R Kroeger; Brad H Nelson
Journal:  Gynecol Oncol       Date:  2016-03-16       Impact factor: 5.482

6.  Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study.

Authors:  Natasha B Leighl; Matthew D Hellmann; Rina Hui; Enric Carcereny; Enriqueta Felip; Myung-Ju Ahn; Joseph Paul Eder; Ani S Balmanoukian; Charu Aggarwal; Leora Horn; Amita Patnaik; Matthew Gubens; Suresh S Ramalingam; Gregory M Lubiniecki; Jin Zhang; Bilal Piperdi; Edward B Garon
Journal:  Lancet Respir Med       Date:  2019-03-12       Impact factor: 30.700

7.  Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma.

Authors:  Christopher B Morse; Mirna N Toukatly; Mark R Kilgore; Kathy J Agnew; Sarah S Bernards; Barbara M Norquist; Kathryn P Pennington; Rochelle L Garcia; John B Liao; Elizabeth M Swisher
Journal:  Gynecol Oncol       Date:  2019-02-23       Impact factor: 5.304

8.  IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.

Authors:  K Abiko; N Matsumura; J Hamanishi; N Horikawa; R Murakami; K Yamaguchi; Y Yoshioka; T Baba; I Konishi; M Mandai
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

9.  Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.

Authors:  Kyle C Strickland; Brooke E Howitt; Sachet A Shukla; Scott Rodig; Lauren L Ritterhouse; Joyce F Liu; Judy E Garber; Dipanjan Chowdhury; Catherine J Wu; Alan D D'Andrea; Ursula A Matulonis; Panagiotis A Konstantinopoulos
Journal:  Oncotarget       Date:  2016-03-22

Review 10.  Ovarian Cancer Immunotherapy: Turning up the Heat.

Authors:  Eleonora Ghisoni; Martina Imbimbo; Stefan Zimmermann; Giorgio Valabrega
Journal:  Int J Mol Sci       Date:  2019-06-15       Impact factor: 5.923
View more
  1 in total

Review 1.  Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer.

Authors:  Giulia Scotto; Fulvio Borella; Margherita Turinetto; Valentina Tuninetti; Anna A Valsecchi; Gaia Giannone; Stefano Cosma; Chiara Benedetto; Giorgio Valabrega
Journal:  Cells       Date:  2021-12-03       Impact factor: 6.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.